Nihon Kohden (NHNKY) Projected to Post Quarterly Earnings on Tuesday

Nihon Kohden (OTCMKTS:NHNKY) is projected to announce its resultson Tuesday, May 12th. Analysts expect the company to announce earnings of $0.24 per share and revenue of $414.3960 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.16 EPS for the quarter. The company had revenue of $362.86 million during the quarter. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%. On average, analysts expect Nihon Kohden to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Nihon Kohden Stock Performance

Nihon Kohden stock opened at $9.13 on Monday. The stock has a market cap of $1.56 billion, a PE ratio of 17.89 and a beta of 0.41. Nihon Kohden has a one year low of $8.93 and a one year high of $14.21. The stock has a fifty day moving average of $9.65 and a 200 day moving average of $10.64.

Analysts Set New Price Targets

A number of analysts recently commented on NHNKY shares. Zacks Research upgraded Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.